Neuromodulatory function of neuropeptides in the normal CNS

Journal of Chemical Neuroanatomy

Volumn 42, Issue 4, 2011, Pages 276-287

  Merighi, Adalberto ^a,b   Salio, Chiara ^a   Ferrini, Francesco ^a   Lossi, Laura ^a,b  

^a UNIVERSITY OF TURIN   (Italy)

^b Istituto Nazionale di Neuroscienze (INN)   (Italy)

Author keywords

Co localization; Coexistence; G protein coupled receptor; Large granular vesicle; Neuropeptides; Synaptic vesicle

Indexed keywords

ACETYLCHOLINE; AMINO ACID; CATECHOLAMINE; G PROTEIN COUPLED RECEPTOR; GROWTH FACTOR; NEUROPEPTIDE; NEUROPEPTIDE RECEPTOR; NEUROTRANSMITTER;

CELL INTERACTION; CELL VACUOLE; CELLULAR DISTRIBUTION; CENTRAL NERVOUS SYSTEM; DENDRITE; DOPAMINERGIC TRANSMISSION; GABAERGIC TRANSMISSION; GLUTAMATERGIC NEUROTRANSMISSION; GRANULAR CELL; IMMUNOCYTOCHEMISTRY; LARGE GRANULAR VESICLE; NERVE CELL; NERVE FIBER; NEUROMODULATION; NEUROTRANSMISSION; PEPTIDE SYNTHESIS; PRIORITY JOURNAL; PROTEIN LOCALIZATION; PROTEIN SECRETION; PROTEIN TARGETING; RECEPTOR BINDING; REVIEW; SEROTONINERGIC TRANSMISSION;

ANIMALS; CENTRAL NERVOUS SYSTEM; HUMANS; NEURONS; NEUROPEPTIDES; NEUROTRANSMITTER AGENTS; SIGNAL TRANSDUCTION;

EID: 80555135388     PISSN: 08910618     EISSN: 18736300     Source Type: Journal    
DOI: 10.1016/j.jchemneu.2011.02.001     Document Type: Review

References (150)

1. Arvidsson U., Cullheim S., Ulfhake B., Luppi P.H., Kitahama K., Jouvet M., Hökfelt T. Quantitative and qualitative aspects on the distribution of 5-HT and its coexistence with substance P and TRH in cat ventral medullary neurons. J. Chem. Neuroanat. 1994, 7:3-12.
2. Artalejo C.R., Elhamdani A., Palfrey H.C. Secretion: dense-core vesicles can kiss-and-run too. Curr. Biol. 1998, 8:R62-R65.
3. Arvieu L., Mauborgne A., Bourgoin S., Oliver C., Feltz P., Hamon M., Cesselin F. Sumatriptan inhibits the release of CGRP and substance P from the rat spinal cord. Neuroreport 1996, 7:1973-1976.
4. Balkowiec A., Katz D.M. Activity-dependent release of endogenous brain-derived neurotrophic factor from primary sensory neurons detected by ELISA in situ. J. Neurosci. 2000, 20:7417-7423.
5. Baranano D.E., Ferris C.D., Snyder S.H. Atypical neural messengers. Trends Neurosci. 2001, 24:99-106.
6. Bardoni R., Merighi A. BDNF and trkB mediated mechanisms in the spinal cord. Synaptic Plasticity in Pain 2009, Springer, New York. M. Malcangio (Ed.).
7. Bardoni R., Ghirri A., Salio C., Prandini M., Merighi A. BDNF-mediated modulation of GABA and glycine release in dorsal horn lamina II from postnatal rats. Dev. Neurobiol. 2007, 67:960-975.
8. Barg S., Olofsson C.S., Schriever-Abeln J., Wendt A., Gebre-Medhin S., Renstrom E., Rorsman P. Delay between fusion pore opening and peptide release from large dense-core vesicles in neuroendocrine cells. Neuron 2002, 33:287-299.
9. Barral J., Mendoza E., Galarraga E., Bargas J. The presynaptic modulation of corticostriatal afferents by mu-opioids is mediated by K+ conductances. Eur. J. Pharmacol. 2003, 462:91-98.
10. Baulieu E.E., Robel P., Schumacher M. Neurosteroids: beginning of the story. Int. Rev. Neurobiol. 2001, 46:1-32.
11. Bean A.J., Zhang X., Hökfelt T. Peptide secretion: what do we know. FASEB J. 1994, 8:630-638.
12. Bencivinni I., Ferrini F., Salio C., Beltramo M., Merighi A. The somatostatin analogue octreotide inhibits capsaicin-mediated activation of nociceptive primary afferent fibres in spinal cord lamina II (substantia gelatinosa). Eur. J. Pain 2010, 10.1016/j.ejpain.2010.11.001.
13. Blakemore L.J., Levenson C.W., Trombley P.Q. Neuropeptide Y modulates excitatory synaptic transmission in the olfactory bulb. Neuroscience 2006, 138:663-674.
14. Bongsebandhu-phubhakdi S., Manabe T. The neuropeptide nociceptin is a synaptically released endogenous inhibitor of hippocampal long-term potentiation. J. Neurosci. 2007, 27:4850-4858.
15. Borgland S.L., Storm E., Bonci A. Orexin B/hypocretin 2 increases glutamatergic transmission to ventral tegmental area neurons. Eur. J. Neurosci. 2008, 28:1545-1556.
16. Braslis K.G., Shulkes A., Fletcher D.R., Hardy K.J. Pharmacokinetics and organ-specific metabolism of calcitonin gene-related peptide in sheep. J. Endocrinol. 1988, 118:25-31.
17. Brigadski T., Hartmann M., Lessmann V. Differential vesicular targeting and time course of synaptic secretion of the mammalian neurotrophins. J. Neurosci. 2005, 25:7601-7614.
18. Brownstein M.J., Russell J.T., Gainer H. Synthesis, transport, and release of posterior pituitary hormones. Science 1980, 207:373-378.
19. Buhler A.V., Choi J., Proudfit H.K., Gebhart G.F. Neurotensin activation of the NTR1 on spinally-projecting serotonergic neurons in the rostral ventromedial medulla is antinociceptive. Pain 2005, 114:285-294.
20. Buma P. Synaptic and nonsynaptic release of neuromediators in the central nervous system. Acta Morphol. Neerl. Scand. 1988, 26:81-113.
21. Burbach J.P. Neuropeptides from concept to online database. Eur. J. Pharmacol. 2010, 626:27-48. http://www.neuropeptides.nl/.
22. Cahill C.M., Morinville A., Lee M.C., Vincent J.P., Collier B., Beaudet A. Prolonged morphine treatment targets delta opioid receptors to neuronal plasma membranes and enhances delta-mediated antinociception. J. Neurosci. 2001, 21:7598-7607.
23. Cauli B., Tong X.K., Rancillac A., Serluca N., Lambolez B., Rossier J., Hamel E. Cortical GABA interneurons in neurovascular coupling: relays for subcortical vasoactive pathways. J. Neurosci. 2004, 24:8940-8949.
24. Collin E., Mantelet S., Frechilla D., Pohl M., Bourgoin S., Hamon M., Cesselin F. Increased in vivo release of calcitonin gene-related peptide-like material from the spinal cord in arthritic rats. Pain 1993, 54:203-211.
25. Collin E., Frechilla D., Pohl M., Bourgoin S., Mauborgne A., Hamon M., Cesselin F. Differential effects of the novel analgesic, S 12813-4, on the spinal release of substance P- and calcitonin gene-related peptide-like materials in the rat. Naunyn Schmiedebergs Arch. Pharmacol. 1994, 349:387-393.
26. Commons K.G. Translocation of presynaptic delta opioid receptors in the ventrolateral periaqueductal gray after swim stress. J. Comp. Neurol. 2003, 464:197-207.
27. Costa L., Santangelo F., Li V.G., Ciranna L. Modulation of AMPA receptor-mediated ion current by pituitary adenylate cyclase-activating polypeptide (PACAP) in CA1 pyramidal neurons from rat hippocampus. Hippocampus 2009, 19:99-109.
28. Cunha-Reis D., Sebastiao A.M., Wirkner K., Illes P., Ribeiro J.A. VIP enhances both pre- and postsynaptic GABAergic transmission to hippocampal interneurones leading to increased excitatory synaptic transmission to CA1 pyramidal cells. Br. J. Pharmacol. 2004, 143:733-744.
29. Davis S.F., Williams K.W., Xu W., Glatzer N.R., Smith B.N. Selective enhancement of synaptic inhibition by hypocretin (orexin) in rat vagal motor neurons: implications for autonomic regulation. J. Neurosci. 2003, 23:3844-3854.
30. De Camilli P., Jahn R. Pathways to regulated exocytosis in neurons. Annu. Rev. Physiol. 1990, 52:625-645.
31. De Wied D. Long term effect of vasopressin on the maintenance of a conditioned avoidance response in rats. Nature 1971, 232:58-60.
32. de Wit J., Toonen R., Verhage M. Matrix-dependent local retention of secretory vesicle cargo in cortical neurons. J. Neurosci. 2009, 29:23-37.
33. Drake C.T., Terman G.W., Simmons M.L., Milner T.A., Kunkel D.D., Schwartzkroin P.A., Chavkin C. Dynorphin opioids present in dentate granule cells may function as retrograde inhibitory neurotransmitters. J. Neurosci. 1994, 14:3736-3750.
34. Dun N.J., Dun S.L., Wong R.K., Forstermann U. Colocalization of nitric oxide synthase and somatostatin immunoreactivity in rat dentate hilar neurons. Proc. Natl. Acad. Sci. U.S.A. 1994, 91:2955-2959.
35. Elhamdani A., Palfrey H.C., Artalejo C.R. Quantal size is dependent on stimulation frequency and calcium entry in calf chromaffin cells. Neuron 2001, 31:819-830.
36. Fawaz C.S., Martel P., Leo D., Trudeau L.E. Presynaptic action of neurotensin on dopamine release through inhibition of D(2) receptor function. BMC Neurosci. 2009, 10:96.
37. Fellin T. Communication between neurons and astrocytes: relevance to the modulation of synaptic and network activity. J. Neurochem. 2009, 108:533-544.
38. Ferrini F., Salio C., Vergnano A.M., Merighi A. Vanilloid receptor-1 (TRPV1)-dependent activation of inhibitory neurotransmission in spinal substantia gelatinosa neurons of mouse. Pain 2007, 129:195-209.
39. Ferrini F., Salio C., Lossi L., Merighi A. Ghrelin in central neurons. Curr. Neuropharmacol. 2009, 7:37-49.
40. Ferrini F., Salio C., Lossi L., Gambino G., Merighi A. Modulation of inhibitory neurotransmission by the vanilloid receptor type 1 (TRPV1) in organotypically cultured mouse substantia gelatinosa neurons. Pain 2010, 150:128-140.
41. Fried G. Neuropeptide storage in vesicles. Neurotransmitter Vesicles 1982, 361-374. Acedemic Press, London/New York. R.L. Klein, H. Lagercrantz, H. Zimmermann (Eds.).
42. Fried G., Terenius L., Hökfelt T., Goldstein M. Evidence for differential localization of noradrenaline and neuropeptide Y (NPY) in neuronal storage vesicles isolated from rat vas deferens. J. Neurosci. 1985, 5:450-458.
43. Gainer H., Fields R.L., House S.B. Vasopressin gene expression: experimental models and strategies. Exp. Neurol. 2001, 171:190-199.
44. Gainer H., Yamashita M., Fields R.L., House S.B., Rusnak M. The magnocellular neuronal phenotype: cell-specific gene expression in the hypothalamo-neurohypophysial system. Prog. Brain Res. 2002, 139:1-14.
45. Gallagher J.P., Orozco-Cabal L.F., Liu J., Shinnick-Gallagher P. Synaptic physiology of central CRH system. Eur. J. Pharmacol. 2008, 583:215-225.
46. Garry M.G., Richardson J.D., Hargreaves K.M. Sodium nitroprusside evokes the release of immunoreactive calcitonin gene-related peptide and substance P from dorsal horn slices via nitric oxide-dependent and nitric oxide-independent mechanisms. J. Neurosci. 1994, 14:4329-4337.
47. Gendron L., Lucido A.L., Mennicken F., O'Donnell D., Vincent J.P., Stroh T., Beaudet A. Morphine and pain-related stimuli enhance cell surface availability of somatic delta-opioid receptors in rat dorsal root ganglia. J. Neurosci. 2006, 26:953-962.
48. Ghijsen W.E., Leenders A.G. Differential signaling in presynaptic neurotransmitter release. Cell Mol. Life Sci. 2005, 62:937-954.
49. Glowinski J., Kemel M.L., Desban M., Gauchy C., Lavielle S., Chassaing G., Beaujouan J.C., Tremblay L. Distinct presynaptic control of dopamine release in striosomal- and matrix-enriched areas of the rat striatum by selective agonists of NK1, NK2 and NK3 tachykinin receptors. Regul. Pept. 1993, 46:124-128.
50. Haj-Dahmane S., Shen R.Y. The wake-promoting peptide orexin-B inhibits glutamatergic transmission to dorsal raphe nucleus serotonin neurons through retrograde endocannabinoid signaling. J. Neurosci. 2005, 25:896-905.
51. Hallberg M., Nyberg F. Neuropeptide conversion to bioactive fragments-an important pathway in neuromodulation. Curr. Protein Pept. Sci. 2003, 4:31-44.
52. Hamm H.E., Gilchrist A. Heterotrimeric G proteins. Curr. Opin. Cell Biol. 1996, 8:189-196.
53. Harata N., Pyle J.L., Aravanis A.M., Mozhayeva M., Kavalali E.T., Tsien R.W. Limited numbers of recycling vesicles in small CNS nerve terminals: implications for neural signaling and vesicular cycling. Trends Neurosci. 2001, 24:637-643.
54. Harling H., Messell T., Poulsen S.S., Rasmussen T.N., Holst J.J. Galanin and vasoactive intestinal polypeptide: coexistence and corelease from the vascularly perfused pig ileum during distension and chemical stimulation of the mucosa. Digestion 1991, 50:61-71.
55. Hirsch M.D., Millington W.R. Endoproteolytic conversion of beta-endorphin-1-31 to beta-endorphin-1-27 potentiates its central cardioregulatory activity. Brain Res. 1991, 550:61-68.
56. Hökfelt T. Neuropeptides in perspective: the last ten years. Neuron 1991, 7:867-879.
57. Hökfelt T. Looking at neurotransmitters in the microscope. Prog. Neurobiol. 2010, 90:101-118.
58. Hökfelt T., Broberger C., Xu Z.Q., Sergeyev V., Ubink R., Diez M. Neuropeptides-an overview. Neuropharmacology 2000, 39:1337-1356.
59. Holm M.M., Nieto-Gonzalez J.L., Vardya I., Vaegter C.B., Nykjaer A., Jensen K. Mature BDNF, but not proBDNF, reduces excitability of fast-spiking interneurons in mouse dentate gyrus. J. Neurosci. 2009, 29:12412-12418.
60. Holst J.J., Fahrenkrug J., Knuhtsen S., Jensen S.L., Nielsen O.V., Lundberg J.M., Hökfelt T. VIP and PHI in the pig pancreas: coexistence, corelease, and cooperative effects. Am. J. Physiol. 1987, 252:G182-G189.
61. Hrabovszky E., Csapó A.K., Kalló I., Wilheim T., Túri G.F., Liposits Z. Localization and osmotic regulation of vesicular glutamate transporter-2 in magnocellular neurons of the rat hypothalamus. Neurochem. Int. 2006, 48:753-761.
62. Iremonger K.J., Bains J.S. Retrograde opioid signaling regulates glutamatergic transmission in the hypothalamus. J. Neurosci. 2009, 29:7349-7358.
63. Jia Y., Gall C.M., Lynch G. Presynaptic BDNF promotes postsynaptic long-term potentiation in the dorsal striatum. J. Neurosci. 2010, 30:14440-14445.
64. Jung L.J., Scheller R.H. Peptide processing and targeting in the neuronal secretory pathway. Science 1991, 251:1330-1335.
65. Karhunen T., Vilim F.S., Alexeeva V., Weiss K.R., Church P.J. Targeting of peptidergic vesicles in cotransmitting terminals. J. Neurosci. 2001, 21:RC127.
66. Kash T.L., Nobis W.P., Matthews R.T., Winder D.G. Dopamine enhances fast excitatory synaptic transmission in the extended amygdala by a CRF-R1-dependent process. J. Neurosci. 2008, 28:13856-13865.
67. Kirby L.G., Freeman-Daniels E., Lemos J.C., Nunan J.D., Lamy C., Akanwa A., Beck S.G. Corticotropin-releasing factor increases GABA synaptic activity and induces inward current in 5-hydroxytryptamine dorsal raphe neurons. J. Neurosci. 2008, 28:12927-12937.
68. Kits K.S., Mansvelder H.D. Regulation of exocytosis in neuroendocrine cells: spatial organization of channels and vesicles, stimulus-secretion coupling, calcium buffers and modulation. Brain Res. Brain Res. Rev. 2000, 33:78-94.
69. Kits K.S., Dreijer A.M., Lodder J.C., Borgdorff A., Wadman W.J. High intracellular calcium levels during and after electrical discharges in molluscan peptidergic neurons. Neuroscience 1997, 79:275-284.
70. Kolaj M., Coderre E., Renaud L.P. Orexin peptides enhance median preoptic nucleus neuronal excitability via postsynaptic membrane depolarization and enhancement of glutamatergic afferents. Neuroscience 2008, 155:1212-1220.
71. Kombian S.B., Ananthalakshmi K.V., Parvathy S.S., Matowe W.C. Cholecystokinin activates CCKB receptors to excite cells and depress EPSCs in the rat rostral nucleus accumbens in vitro. J. Physiol. 2004, 555:71-84.
72. Kupfermann I. Functional studies of cotransmission. Physiol. Rev. 1991, 71:683-732.
73. Landgraf R., Neumann I.D. Vasopressin and oxytocin release within the brain: a dynamic concept of multiple and variable modes of neuropeptide communication. Front. Neuroendocrinol. 2004, 25:150-176.
74. Landry M., Vila-Porcile E., Hökfelt T., Calas A. Differential routing of coexisting neuropeptides in vasopressin neurons. Eur. J. Neurosci. 2003, 17:579-589.
75. Landry M., Liu H.-X., Shi T.-J., Brumovsky P., Nagy F., Hökfelt T. Galaninergic mechanisms at the spinal level: focus on histochemical phenotyping. Neuropeptides 2005, 39:223-231.
76. Lemtiri-Chlieh F., Levine E.S. BDNF evokes release of endogenous cannabinoids at layer 2/3 inhibitory synapses in the neocortex. J. Neurophysiol. 2010, 104:1923-1932.
77. Lessmann V., Gottmann K., Malcangio M. Neurotrophin secretion: current facts and future prospects. Prog. Neurobiol. 2003, 69:341-374.
78. Lopez-Huerta V.G., Tecuapetla F., Guzman J.N., Bargas J., Galarraga E. Presynaptic modulation by somatostatin in the neostriatum. Neurochem. Res. 2008, 33:1452-1458.
79. Ludwig M., Leng G. Dendritic peptide release and peptide-dependent behaviours. Nat. Rev. Neurosci. 2006, 7:126-136.
80. Macdonald D.S., Weerapura M., Beazely M.A., Martin L., Czerwinski W., Roder J.C., Orser B.A., MacDonald J.F. Modulation of NMDA receptors by pituitary adenylate cyclase activating peptide in CA1 neurons requires G alpha q, protein kinase C, and activation of Src. J. Neurosci. 2005, 25:11374-11384.
81. Malcangio M., Bowery N.G. Peptide autoreceptors: does an autoreceptor for substance P exist?. Trends Pharmacol. Sci. 1999, 20:405-407.
82. Mantyh P.W., Allen C.J., Ghilardi J.R., Rogers S.D., Mantyh C.R., Liu H., Basbaum A.I., Vigna S.R., Maggio J.E. Rapid endocytosis of a G protein-coupled receptor: substance P-evoked internalization of its receptor in the rat striatum in vivo. Proc. Natl. Acad. Sci. U.S.A. 1995, 92:2622-2626.
83. Mantyh P.W., DeMaster E., Malhotra A., Ghilardi J.R., Rogers S.D., Mantyh C.R., Liu H., Basbaum A.I., Vigna S.R., Maggio J.E., Simone D.A. Receptor endocytosis and dendrite reshaping in spinal neurons after somatosensory stimulation. Science 1995, 268:1629-1632.
84. Marco N., Thirion A., Mons G., Bougault I., Le F.G., Soubrie P., Steinberg R. Activation of dopaminergic and cholinergic neurotransmission by tachykinin NK3 receptor stimulation: an in vivo microdialysis approach in guinea pig. Neuropeptides 1998, 32:481-488.
85. Marti M., Manzalini M., Fantin M., Bianchi C., Della C.L., Morari M. Striatal glutamate release evoked in vivo by NMDA is dependent upon ongoing neuronal activity in the substantia nigra, endogenous striatal substance P and dopamine. J. Neurochem. 2005, 93:195-205.
86. Marti M., Mela F., Fantin M., Zucchini S., Brown J.M., Witta J., Di B.M., Buzas B., Reinscheid R.K., Salvadori S., Guerrini R., Romualdi P., Candeletti S., Simonato M., Cox B.M., Morari M. Blockade of nociceptin/orphanin FQ transmission attenuates symptoms and neurodegeneration associated with Parkinson's disease. J. Neurosci. 2005, 25:9591-9601.
87. Martin T.F. Tuning exocytosis for speed: fast and slow modes. Biochim. Biophys. Acta 2003, 1641:157-165.
88. Martinez-Rodriguez R., Martinez-Murillo R. Molecular and cellular aspects of neurotransmission and neuromodulation. Int. Rev. Cytol. 1994, 149:217-292.
89. Meis S., Pape H.C. Control of glutamate and GABA release by nociceptin/orphanin FQ in the rat lateral amygdala. J. Physiol. 2001, 532:701-712.
90. Meis S., Munsch T., Pape H.C. Antioscillatory effects of nociceptin/orphanin FQ in synaptic networks of the rat thalamus. J. Neurosci. 2002, 22:718-727.
91. Mens W.B., Witter A., Wimersma Greidanus T.B. Penetration of neurohypophyseal hormones from plasma into cerebrospinal fluid (CSF): half-times of disappearance of these neuropeptides from CSF. Brain Res. 1983, 262:143-149.
92. Merighi A. Costorage and coexistence of neuropeptides in the mammalian CNS. Progr. Neurobiol. 2002, 66:161-190.
93. Merighi A. Neuropeptides and coexistence. Encyclopedia of Neuroscience 2009, 843-849. Academic Press, Oxford. L.R. Squire (Ed.).
94. Merighi A., Salio C. Use of gold-labeled antibodies for ultrastructural localization of neurotrophic factors and their receptors in somatosensory pathways. 2nd International Congress on Antibodies, BIT Life Sciences 2010.
95. Merighi A., Polak J.M., Gibson S.J., Gulbenkian S., Valentino K.L., Peirone S.M. Ultrastructural studies on calcitonin gene-related peptide-, tachykinins- and somatostatin-immunoreactive neurones in rat dorsal root ganglia: evidence for the colocalisation of different peptides in single secretory granules. Cell Tissue Res. 1988, 254:101-109.
96. Merighi A., Bardoni R., Salio C., Lossi L., Ferrini F., Prandini M., Zonta M., Gustincich S., Carmignoto G. Presynaptic functional trkB receptors mediate the release of excitatory neurotransmitters from primary afferent terminals in lamina II (substantia gelatinosa) of postnatal rat spinal cord. Dev. Neurobiol. 2008, 68:457-475.
97. Merighi A., Salio C., Ghirri A., Lossi L., Ferrini F., Betelli C., Bardoni R. BDNF as a pain modulator. Prog. Neurobiol. 2008, 85:297-317.
98. Michel S., Itri J., Han J.H., Gniotczynski K., Colwell C.S. Regulation of glutamatergic signalling by PACAP in the mammalian suprachiasmatic nucleus. BMC Neurosci. 2006, 7:15.
99. Mitchell V.A., Kawahara H., Vaughan C.W. Neurotensin inhibition of GABAergic transmission via mGluR-induced endocannabinoid signalling in rat periaqueductal grey. J. Physiol. 2009, 587:2511-2520.
100. Nillni E.A. Regulation of the hypothalamic thyrotropin releasing hormone (TRH) neuron by neuronal and peripheral inputs. Front. Neuroendocrinol. 2010, 31:134-156.
101. Ohbuchi T., Yokoyama T., Saito T., Hashimoto H., Suzuki H., Otsubo H., Fujihara H., Suzuki H., Ueta Y. Brain-derived neurotrophic factor inhibits spontaneous inhibitory postsynaptic currents in the rat supraoptic nucleus. Brain Res. 2009, 1258:34-42.
102. Paredes D., Granholm A.C., Bickford P.C. Effects of NGF and BDNF on baseline glutamate and dopamine release in the hippocampal formation of the adult rat. Brain Res. 2007, 1141:56-64.
103. Pasternak G.W., Wood P.J. Multiple mu opiate receptors. Life Sci. 1986, 38:1889-1898.
104. Perrais D., Kleppe I.C., Taraska J.W., Almers W. Recapture after exocytosis causes differential retention of protein in granules of bovine chromaffin cells. J. Physiol. 2004, 560:413-428.
105. Peters W. The Fine Structure of the Nervous System 1976, WB Saunders Company, Philadelphia. A. Peters, S.L. Palay, H. Webster (Eds.).
106. Pow D.V., Morris J.F. Dendrites of hypothalamic magnocellular neurons release neurohypophysial peptides by exocytosis. Neuroscience 1989, 32:435-439.
107. Pritchard L.E., Turnbull A.V., White A. Pro-opiomelanocortin processing in the hypothalamus: impact on melanocortin signalling and obesity. J. Endocrinol. 2002, 172:411-421.
108. Quarta D., Leslie C.P., Carletti R., Valerio E., Caberlotto L. Central administration of NPY or an NPY-Y5 selective agonist increase in vivo extracellular monoamine levels in mesocorticolimbic projecting areas. Neuropharmacology 2011, 60:328-335.
109. Rao Y., Lu M., Ge F., Marsh D.J., Qian S., Wang A.H., Picciotto M.R., Gao X.B. Regulation of synaptic efficacy in hypocretin/orexin-containing neurons by melanin concentrating hormone in the lateral hypothalamus. J. Neurosci. 2008, 28:9101-9110.
110. Roberto M., Siggins G.R. Nociceptin/orphanin FQ presynaptically decreases GABAergic transmission and blocks the ethanol-induced increase of GABA release in central amygdala. Proc. Natl. Acad. Sci. U.S.A. 2006, 103:9715-9720.
111. Saleh T.M. Visceral afferent stimulation-evoked changes in the release of peptides into the parabrachial nucleus in vivo. Brain Res. 1997, 778:56-63.
112. Salio C., Lossi L., Ferrini F., Merighi A. Ultrastructural evidence for a pre- and postsynaptic localization of full-length trkB receptors in substantia gelatinosa (lamina II) of rat and mouse spinal cord. Eur. J. Neurosci. 2005, 22:1951-1966.
113. Salio C., Lossi L., Ferrini F., Merighi A. Neuropeptides as synaptic transmitters. Cell Tissue Res. 2006, 326:583-598.
114. Salio C., Averill S., Priestley J.V., Merighi A. Costorage of BDNF and neuropeptides within individual dense-core vesicles in central and peripheral neurons. Dev. Neurobiol. 2007, 67:326-338.
115. Salio, C., Lossi, L., Merighi, A. Combined light and electron microscopic localization of neuropeptides and their receptors in central neurons. In: Merighi, A. (Ed.), Neuropeptides Methods and Protocols. Methods in Molecular Biology. Humana Press, New York, in press.
116. Sekizawa S., Joad J.P., Bonham A.C. Substance P presynaptically depresses the transmission of sensory input to bronchopulmonary neurons in the guinea pig nucleus tractus solitarii. J. Physiol. 2003, 552:547-559.
117. Selmer I., Schindler M., Allen J.P., Humphrey P.P., Emson P.C. Advances in understanding neuronal somatostatin receptors. Regul. Pept. 2000, 90:1-18.
118. Shuster S.J., Riedl M., Li X., Vulchanova L., Elde R. Stimulus-dependent translocation of kappa opioid receptors to the plasma membrane. J. Neurosci. 1999, 19:2658-2664.
119. Silva A.P., Xapelli S., Pinheiro P.S., Ferreira R., Lourenco J., Cristovao A., Grouzmann E., Cavadas C., Oliveira C.R., Malva J.O. Up-regulation of neuropeptide Y levels and modulation of glutamate release through neuropeptide Y receptors in the hippocampus of kainate-induced epileptic rats. J. Neurochem. 2005, 93:163-170.
120. Smith B.N., Davis S.F., van den Pol A.N., Xu W. Selective enhancement of excitatory synaptic activity in the rat nucleus tractus solitarius by hypocretin 2. Neuroscience 2002, 115:707-714.
121. Südhof T.C. Neurotransmitter release. Handb. Exp. Pharmacol. 2008, 184:1-21.
122. Summy-Long J.Y., Hu S., Long A., Phillips T.M. Interleukin-1beta release in the supraoptic nucleus area during osmotic stimulation requires neural function. J. Neuroendocrinol. 2008, 20:1224-1232.
123. Szapiro G., Barbour B. Parasynaptic signalling by fast neurotransmitters: the cerebellar cortex. Neuroscience 2009, 162:644-655.
124. Tallent M.K. Presynaptic inhibition of glutamate release by neuropeptides: use-dependent synaptic modification. Results Probl. Cell Differ. 2008, 44:177-200.
125. Tallent M.K., Madamba S.G., Siggins G.R. Nociceptin reduces epileptiform events in CA3 hippocampus via presynaptic and postsynaptic mechanisms. J. Neurosci. 2001, 21:6940-6948.
126. Teng H.K., Teng K.K., Lee R., Wright S., Tevar S., Almeida R.D., Kermani P., Torkin R., Chen Z.Y., Lee F.S., Kraemer R.T., Nykjaer A., Hempstead B.L. ProBDNF induces neuronal apoptosis via activation of a receptor complex of p75NTR and sortilin. J. Neurosci. 2005, 25:5455-5463.
127. Theodosis D.T., Chapman D.B., Montagnese C., Poulain D.A., Morris J.F. Structural plasticity in the hypothalamic supraoptic nucleus at lactation affects oxitocin-but not vasopressin-secreting neurones. Neuroscience 1986, 17:661-678.
128. Thureson-Klein Å.K., Klein R.L., Zhu P.C., Kong J.-Y. Differential release of transmitters and neuropeptides co-stored in central and peripheral neurons. Cellular and Molecular Basis of Synaptic Transmission 1988, 171-183. Springer-Verlag, Berlin/New York. H. Zimmermann (Ed.).
129. Tsuboi T., Rutter G.A. Insulin secretion by 'kiss-and-run' exocytosis in clonal pancreatic islet beta-cells. Biochem. Soc. Trans. 2003, 31:833-836.
130. van Leeuwen F.W., Verwer R.W., Spence H., Evans D.A., Burbach J.P. The magnocellular neurons of the hypothalamo-neurohypophyseal system display remarkable neuropeptidergic phenotypes leading to novel insights in neuronal cell biology. Prog. Brain Res. 1998, 119:115-126.
131. Vanner S. Corelease of neuropeptides from capsaicin-sensitive afferents dilates submucosal arterioles in guinea pig ileum. Am. J. Physiol. 1994, 267:G650-G655.
132. Vaughan C.W., Christie M.J. Presynaptic inhibitory action of opioids on synaptic transmission in the rat periaqueductal grey in vitro. J. Physiol. 1997, 498:463-472.
133. Vaughan C.W., Ingram S.L., Connor M.A., Christie M.J. How opioids inhibit GABA-mediated neurotransmission. Nature 1997, 390:611-614.
134. Vergnano A.M., Salio C., Merighi A. NK1 receptor activation leads to enhancement of inhibitory neurotransmission in spinal substantia gelatinosa neurons of mouse. Pain 2004, 112:37-47.
135. Vergnano A.M., Ferrini F., Salio C., Lossi L., Baratta M., Merighi A. The gastrointestinal hormone ghrelin modulates inhibitory neurotransmission in deep laminae of mouse spinal cord dorsal horn. Endocrinology 2008, 149:2306-2312.
136. Verhage M., McMahon H.T., Ghijsen W.E., Boomsma F., Scholten G., Wiegant V.M., Nicholls D.G. Differential release of amino acids, neuropeptides, and catecholamines from isolated nerve terminals. Neuron 1991, 6:517-524.
137. Wan S., Browning K.N., Coleman F.H., Sutton G., Zheng H., Butler A., Berthoud H.R., Travagli R.A. Presynaptic melanocortin-4 receptors on vagal afferent fibers modulate the excitability of rat nucleus tractus solitarius neurons. J. Neurosci. 2008, 28:4957-4966.
138. Wanat M.J., Hopf F.W., Stuber G.D., Phillips P.E., Bonci A. Corticotropin-releasing factor increases mouse ventral tegmental area dopamine neuron firing through a protein kinase C-dependent enhancement of Ih. J. Physiol. 2008, 586:2157-2170.
139. Wank S.A. Cholecystokinin receptors. Am. J. Physiol. 1995, 269:G628-G646.
140. Watson S., Arkinstall S. The G-protein Linked Receptor-Facts Book 1994, San Diego Academic, San Diego.
141. Weiss J.M., Boss-Williams K.A., Moore J.P., Demetrikopoulos M.K., Ritchie J.C., West C.H. Testing the hypothesis that locus coeruleus hyperactivity produces depression-related changes via galanin. Neuropeptides 2005, 39:281-287.
142. Weisskopf M.G., Zalutsky R.A., Nicoll R.A. The opioid peptide dynorphin mediates heterosynaptic depression of hippocampal mossy fibre synapses and modulates long-term potentiation. Nature 1993, 362:423-427.
143. Woo N.H., Teng H.K., Siao C.J., Chiaruttini C., Pang P.T., Milner T.A., Hempstead B.L., Lu B. Activation of p75NTR by proBDNF facilitates hippocampal long-term depression. Nat. Neurosci. 2005, 8:1069-1077.
144. Xu X.J., Hökfelt T., Wiesenfeld-Hallin Z. Galanin and spinal pain mechanisms: where do we stand in 2008?. Cell. Mol. Life Sci. 2008, 65:1813-1819.
145. Yang J., Siao C.J., Nagappan G., Marinic T., Jing D., McGrath K., Chen Z.Y., Mark W., Tessarollo L., Lee F.S., Lu B., Hempstead B.L. Neuronal release of proBDNF. Nat. Neurosci. 2009, 12:113-115.
146. Yang L., Thomas N.D., Helke C.J. Characterization of substance P release from the intermediate area of rat thoracic spinal cord. Synapse 1996, 23:265-273.
147. Yang Y., Ozawa H., Yuri K., Kawata M. Postnatal development of NADPH-diaphorase activity in the rat: the role of nitric oxide in the ontogeny of arginine vasopression and oxytocin. Endocr. J. 2000, 47:601-613.
148. Zhu P.C., Thureson-Klein Å.K., Klein R.L. Exocytosis from large dense cored vesicles outside the active synaptic zones of terminals within the trigeminal subnucleus caudalis:a possible mechanism for neuropeptide release. Neuroscience 1986, 19:43-54.
149. Zhu W., Pan Z.Z. Mu-opioid-mediated inhibition of glutamate synaptic transmission in rat central amygdala neurons. Neuroscience 2005, 133:97-103.
150. Zoli M., Agnati L.F., Jansson A., Fuxe K., Syková E. Volume transmission in the CNS and its relevance for neurophyschopharmacology. Trends Physiol. Sci. 1999, 20:142-150.